Published in Am J Physiol on March 01, 1986
Myocardial microinfarction after coronary microembolization in swine: MR imaging characterization. Radiology (2009) 1.68
Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors. J Clin Invest (1996) 1.57
Pathophysiology and pathogenesis of stunned myocardium. Depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest (1987) 1.41
Cellular mechanism of the modulation of contractile function by coronary perfusion pressure in ferret hearts. J Physiol (1989) 0.92
TNF-α-induced cardiomyocyte apoptosis contributes to cardiac dysfunction after coronary microembolization in mini-pigs. J Cell Mol Med (2014) 0.90
Attenuation of exercise vasodilatation by adenosine deaminase in anaesthetized dogs. J Physiol (1991) 0.85
Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization. Arch Med Sci (2012) 0.83
Impact of Distal Protection with Filter-Type Device on Long-term Outcome after Percutaneous Coronary Intervention for Acute Myocardial Infarction: Clinical Results with Filtrap(®). J Atheroscler Thromb (2016) 0.81
Early changes in myocardial microcirculation in asymptomatic hypercholesterolemic subjects: as detected by perfusion CT. Ann Biomed Eng (2014) 0.78
Complications of coronary intervention: device embolisation, no-reflow, air embolism. Heart Asia (2013) 0.76
It is time to ask what adenosine can do for cardioprotection. Heart Vessels (1998) 0.76
Spontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and prevention. Scientifica (Cairo) (2013) 0.75
Percutaneous microembolization of the left coronary artery to model ischemic heart disease in rats. Lab Anim (NY) (2015) 0.75
Coronary Microembolization with Normal Epicardial Coronary Arteries and No Visible Infarcts on Nitrobluetetrazolium Chloride-Stained Specimens: Evaluation with Cardiac Magnetic Resonance Imaging in a Swine Model. Korean J Radiol (2016) 0.75
A possible model of the anginal syndrome with normal coronary arteriograms: microembolization of canine coronary arteries. Heart Vessels (1987) 0.75
Pathophysiology of coronary microembolisation. Heart (2003) 0.75
No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction. Chonnam Med J (2016) 0.75
Electrical analogy of diastolic pressure difference between left atrium and ventricle. Med Biol Eng Comput (1994) 0.75
Transformation of intact yeast cells treated with alkali cations. J Bacteriol (1983) 100.26
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother (1980) 26.28
In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother (1982) 21.31
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci U S A (1971) 11.41
Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother (1994) 8.64
Combinatorial receptor codes for odors. Cell (1999) 8.63
Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections. Antimicrob Agents Chemother (1981) 8.59
Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA. Appl Environ Microbiol (1998) 8.58
THE ETIOLOGY, MODE OF INFECTION, AND SPECIFIC THERAPY OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 8.21
Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother (1982) 7.11
Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. J Bacteriol (1986) 6.97
PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol (1996) 6.68
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature (2000) 6.58
Solid phase synthesis of polynucleotides. VI. Further studies on polystyrene copolymers for the solid support. Nucleic Acids Res (1982) 6.38
A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1995) 6.00
Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother (1989) 5.98
Role of lipopolysaccharides in antibiotic resistance and bacteriophage adsorption of Escherichia coli K-12. J Bacteriol (1971) 5.83
Fgf10 is essential for limb and lung formation. Nat Genet (1999) 5.76
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ (2004) 5.49
Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob Agents Chemother (1996) 5.36
Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation (1983) 4.70
Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell (1995) 4.53
Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem (1999) 4.38
In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrob Agents Chemother (1989) 4.38
PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis (2004) 4.33
THE PROPHYLAXIS OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 4.33
A modified method for lead staining of thin sections. J Electron Microsc (Tokyo) (1968) 4.25
Synthesis and assembly of the membrane proteins in E. coli. Cell (1977) 4.18
Purification and properties of a new beta-lactamase from Pseudomonas cepacia. Antimicrob Agents Chemother (1980) 4.09
Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature (1988) 3.99
Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula. Aliment Pharmacol Ther (2012) 3.91
In vitro and in vivo activity of NY-198, a new difluorinated quinolone. Antimicrob Agents Chemother (1987) 3.84
THE RAT AS A CARRIER OF SPIROCHAETA ICTEROHAEMORRHAGIAE, THE CAUSATIVE AGENT OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1917) 3.80
In vitro and in vivo antibacterial activity of AT-2266. Antimicrob Agents Chemother (1983) 3.80
Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli. Antimicrob Agents Chemother (1986) 3.69
Biochemical properties of beta-lactamase produced by Flavobacterium odoratum. Antimicrob Agents Chemother (1985) 3.62
Properties of novel beta-lactamase produced by Bacteroides fragilis. Antimicrob Agents Chemother (1983) 3.59
Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature (1985) 3.59
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone. Antimicrob Agents Chemother (1988) 3.52
Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae. Antimicrob Agents Chemother (1980) 3.48
Structural similarity among Escherichia coli FtsW and RodA proteins and Bacillus subtilis SpoVE protein, which function in cell division, cell elongation, and spore formation, respectively. J Bacteriol (1989) 3.41
A metalloprotease-disintegrin participating in myoblast fusion. Nature (1995) 3.24
THE SERUM TREATMENT OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 3.24
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
Molecular epidemiologic evidence for association of thermostable direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus with gastroenteritis. Infect Immun (1990) 3.17
In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrob Agents Chemother (1987) 3.12
Classification criteria for polymyositis and dermatomyositis. J Rheumatol (1995) 3.08
Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type beta-lactamase. Gene (1994) 3.08
IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol (2000) 3.08
Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrob Agents Chemother (1984) 3.07
Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet (1996) 3.07
Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant. J Bacteriol (1987) 3.04
Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem (1977) 3.02
Studies on the mass receptor potential of the isolated frog retina. II. On the basis of the ionic mechanism. Vision Res (1969) 2.91
Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol (1994) 2.89
Room-temperature reversible spin Hall effect. Phys Rev Lett (2007) 2.80
Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation (1998) 2.79
Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J Biol Chem (1996) 2.79
Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins. Antimicrob Agents Chemother (1980) 2.76
Effects of the complete removal of basic amino acid residues from the signal peptide on secretion of lipoprotein in Escherichia coli. J Biol Chem (1983) 2.66
Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med (1997) 2.64
Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med (1997) 2.59
Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation (1993) 2.56
Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains. Antimicrob Agents Chemother (1980) 2.53
Health risks of heavy metals to the general public in Tianjin, China via consumption of vegetables and fish. Sci Total Environ (2005) 2.48
Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48
Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid. J Bacteriol (1995) 2.47
Immobilized aspartase-containing microbial cells: preparation and enzymatic properties. Appl Microbiol (1974) 2.46
Purification and some properties of a cephalosporinase from Proteus vulgaris. Antimicrob Agents Chemother (1981) 2.42
Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A (1991) 2.39
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A (1992) 2.37
Purification and properties of a cephalosporinase from Enterobacter cloacae. Antimicrob Agents Chemother (1980) 2.37
25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science (1997) 2.36
Characterization and genetic analysis of a mutant of Escherichia coli K-12 with rounded morphology. J Bacteriol (1973) 2.36
Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem (1995) 2.35
Chlorophyll a oxygenase (CAO) is involved in chlorophyll b formation from chlorophyll a. Proc Natl Acad Sci U S A (1998) 2.35
Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33
Metabolism of polycyclic compounds. 17. The reaction of 1:2-dihydronaphthalene and 1:2-epoxy-1:2:3:4-tetrahydronaphthalene with glutathione catalysed by tissue preparations. Biochem J (1960) 2.31
Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res (1994) 2.29
Ultrasonic imaging of internal vibration of soft tissue under forced vibration. IEEE Trans Ultrason Ferroelectr Freq Control (1990) 2.29
Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391. J Gen Microbiol (1980) 2.28
Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother (1982) 2.27
Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs. J Biol Chem (1995) 2.25
Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol (1994) 2.23
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun (1989) 2.23
A large family of class III plant peroxidases. Plant Cell Physiol (2001) 2.21
Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res (1993) 2.20
Computer simulation of tablet motion in coating drum. Pharm Res (1995) 2.20
Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J Exp Med (1995) 2.17
Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature (1998) 2.17
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med (2000) 2.16
Evaluation of central serous chorioretinopathy with optical coherence tomography. Am J Ophthalmol (2000) 2.15
BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem (1996) 2.14
Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun (1992) 2.11
Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med (1998) 2.11
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int (2006) 2.10